APA (7th ed.) Citation

Pan, L., Wang, Y., Li, Z., Luo, J., Wu, K., Liu, Z., . . . Zhong, J. (2024). Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: Study protocol for a randomized, open-label trial. Trials, 25(1), 1. https://doi.org/10.1186/s13063-023-07742-x

Chicago Style (17th ed.) Citation

Pan, Li-Xin, et al. "Entecavir Versus Tenofovir for Prevention of Hepatitis B Virus-associated Hepatocellular Carcinoma After Curative Resection: Study Protocol for a Randomized, Open-label Trial." Trials 25, no. 1 (2024): 1. https://doi.org/10.1186/s13063-023-07742-x.

MLA (9th ed.) Citation

Pan, Li-Xin, et al. "Entecavir Versus Tenofovir for Prevention of Hepatitis B Virus-associated Hepatocellular Carcinoma After Curative Resection: Study Protocol for a Randomized, Open-label Trial." Trials, vol. 25, no. 1, 2024, p. 1, https://doi.org/10.1186/s13063-023-07742-x.